CD47-signal regulatory protein α signaling system and its application to cancer immunotherapy

Yoji Murata1, Yasuyuki Saito1, Takenori Kotani1

  • 1Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, Kobe, Japan.

Cancer Science
|June 7, 2018
PubMed

Insights

Blocking the CD47-SIRPα pathway enhances immune cell activity against cancer cells. This approach shows promise for new cancer treatments by boosting both innate and adaptive immune responses.

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Background:

  • Tumor cells evade immune surveillance by interacting with immune cells.
  • The CD47-SIRPα axis is a key cell-cell communication system involved in immune evasion.
  • CD47 is upregulated on cancer cells, while SIRPα is abundant on myeloid immune cells.

Purpose of the Study:

  • To investigate the therapeutic potential of targeting the CD47-SIRPα interaction in cancer treatment.
  • To evaluate the impact of CD47-SIRPα blockade on immune cell-mediated tumor cell clearance.
  • To explore combination strategies involving CD47-SIRPα blockade and immune checkpoint inhibitors.

Main Methods:

  • Utilizing biological agents like antibodies and recombinant proteins to block CD47 or SIRPα.
  • Testing blockade strategies in in vitro assays and in vivo preclinical cancer models (xenograft and syngeneic).
  • Assessing enhancement of phagocytic activity and stimulation of cytotoxic T cells.

Main Results:

  • CD47-SIRPα blockade significantly enhances macrophage phagocytosis of tumor cells in vitro.
  • Blockade leads to efficient tumor cell eradication in various mouse cancer models.
  • CD47 blockade promotes the activation of tumor-specific cytotoxic T cells by antigen-presenting cells.
  • Preclinical studies suggest synergistic antitumor effects when combined with immune checkpoint inhibitors.

Conclusions:

  • Targeting the CD47-SIRPα signaling pathway is a promising cancer immunotherapy strategy.
  • Modulating this axis enhances both innate (phagocytosis) and adaptive (T cell) immune responses against tumors.
  • Combination therapies involving CD47-SIRPα blockade offer potential for improved cancer treatment outcomes.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.8K
Endocrine Signaling01:45

Endocrine Signaling

Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
68.2K
Yeast Signaling01:28

Yeast Signaling

Yeasts are single-celled organisms, but unlike bacteria, they are eukaryotes (cells with a nucleus). Cell signaling in yeast is similar to signaling in other eukaryotic cells. A ligand, such as a protein or a small molecule released from a yeast cell, attaches to a receptor on the cell surface. The binding stimulates second-messenger kinases to activate or inactivate transcription factors that further regulate gene expression. Many of the yeast intracellular signaling cascades have similar...
17.3K
Bacterial Signaling01:30

Bacterial Signaling

Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
40.9K
What is Cell Signaling?02:03

What is Cell Signaling?

Despite the protective membrane that separates a cell from the environment, cells need the ability to detect and respond to environmental changes. Additionally, cells often need to communicate with one another. Unicellular and multicellular organisms use a variety of cell signaling mechanisms to communicate to respond to the environment.
131.0K
Paracrine Signaling01:21

Paracrine Signaling

Paracrine signaling allows cells to communicate with their immediate neighbors via secretion of signaling molecules. Such a signal can only trigger a response in nearby target cells because the signal molecules degrade quickly or are inactivated if not taken up. Prominent examples of paracrine signaling include nitric oxide signaling in blood vessels, synaptic signaling of neurons, the blood clotting system, tissue repair/wound healing, and local allergic skin reactions. Nitric oxide as a...
59.7K